Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.India |
First Approval Date30 Apr 2016 |
100 Clinical Results associated with Cipla Pharma & Life Sciences Ltd.
0 Patents (Medical) associated with Cipla Pharma & Life Sciences Ltd.
100 Deals associated with Cipla Pharma & Life Sciences Ltd.
100 Translational Medicine associated with Cipla Pharma & Life Sciences Ltd.